Robert Rosenson, MD, Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai, and Director of Lipids and Metabolism for the Mount Sinai Health System (IMAGE)

The Mount Sinai Hospital / Mount Sinai School of Medicine

Robert Rosenson, MD, Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai, and Director of Lipids and Metabolism for the Mount Sinai Health System

Caption

Dr. Rosenson leads a late-breaking clinical trial on an investigational RNA inhibitor that's shown to be safe and effective in reducing a wide range of cholesterol and triglyceride levels in the blood

 

Credit

Mount Sinai Health System

Usage Restrictions

use with credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.